ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,285.52
0.04%
S&P 500
5,308.15
1.17%
Dow Jones
39,908.00
0.88%
US Dollar vs Yen
154.656
0.24%
Brent Oil
82.445
-0.25%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. EyePoint Pharmaceuticals Inc (EYPT)

  7. EyePoint Pharmaceuticals Inc (EYPT) ニュース

EYPT EyePoint Pharmaceuticals Inc

12.94
0.00 (0.00%)
プレマーケット
最終更新日： 17:43:05
15分遅延
名称 銘柄コード 市場 種別
EyePoint Pharmaceuticals Inc EYPT NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.00 0.00% 12.94 17:43:05
始値 安値 高値 終値 前日終値
12.94
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0923:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0905:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/0820:05EDGAR2Form 8-K - Current report
2024/5/0820:00GLOBEEyePoint Pharmaceuticals Reports First Quarter 2024..
2024/5/0622:25EDGAR2Form 8-K - Current report
2024/5/0620:00GLOBEEyePoint Pharmaceuticals Announces Topline Data from the..
2024/4/1620:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
2024/4/0220:00GLOBEEyePoint Pharmaceuticals Expands Scientific Advisory Board..
2024/3/1820:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
2024/3/0903:53EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0721:05EDGAR2Form 8-K - Current report
2024/3/0721:00GLOBEEyePoint Pharmaceuticals Reports Fourth Quarter and..
2024/3/0507:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0507:37EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/3/0421:01EDGAR2Form 8-K - Current report
2024/3/0421:00GLOBEEyePoint Pharmaceuticals Announces Appointment of Ramiro..
2024/2/2921:00GLOBEEyePoint Pharmaceuticals to Report Fourth Quarter and..
2024/2/2721:00GLOBEEyePoint Pharmaceuticals Announces Participation at Upcoming..
2024/2/2307:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1621:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
2024/2/1511:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1407:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1407:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1407:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1407:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1407:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1402:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0607:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0406:20GLOBEEyePoint Pharmaceuticals Announces Two Presentations of..
2024/2/0306:22EDGAR2Form 144 - Report of proposed sale of securities
2024/1/3121:00GLOBEEyePoint Pharmaceuticals to Present at the Guggenheim..
2024/1/3106:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3007:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3007:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2707:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2608:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2608:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2506:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2506:25EDGAR2Form 144 - Report of proposed sale of securities
2024/1/2506:17EDGAR2Form 144 - Report of proposed sale of securities
2024/1/2406:42EDGAR2Form 144 - Report of proposed sale of securities
2024/1/2406:19EDGAR2Form 144 - Report of proposed sale of securities
2024/1/2306:19EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1708:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1708:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1621:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
2024/1/1207:33EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1206:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1106:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1021:05EDGAR2Form 8-K - Current report

最近閲覧した銘柄

NASDAQ
EYPT
EyePoint Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有